Vincenzo Brescia Morra
Università degli Studi di Napoli Federico II
H-index: 46
Europe-Italy
Top articles of Vincenzo Brescia Morra
Title | Journal | Author(s) | Publication Date |
---|---|---|---|
Evaluation of drivers of treatment switch in relapsing multiple sclerosis: a study from the Italian MS Registry | Journal of Neurology | Pietro Iaffaldano Giuseppe Lucisano Tommaso Guerra Francesco Patti Eleonora Cocco | 2024/3 |
Intravenous or subcutaneous natalizumab in patients with relapsing–remitting multiple sclerosis: investigation on efficiency and savings—the EASIER study | Journal of Neurology | Massimo Filippi Luigi Grimaldi Antonella Conte Rocco Totaro Maria Rosaria Valente | 2024/1 |
Effect of siponimod on lymphocyte subsets in active secondary progressive multiple sclerosis and clinical implications | Journal of Neurology | Antonio Luca Spiezia Giulia Scalia Maria Petracca Daniele Caliendo Marcello Moccia | 2024/4/17 |
Spectral Domain and Angiography Optical Coherence Tomography in Parkinson’s Disease: Structural And Vascular Changes in the Retina Correlate with Disease Severity and Progression | Acta Neurologica Scandinavica | Laura Giovanna Di Maio Gilda Cennamo Daniela Montorio Giovanna De Michele Gianluigi Rosario Palmieri | 2024/4/15 |
Neurofilament in clinical practice: Is the multiple sclerosis community ready? | Multiple Sclerosis Journal | Marcello Moccia Daniela Terracciano Vincenzo Brescia Morra Giuseppe Castaldo | 2024/4/11 |
Utilization of Ocrelizumab within Different Treatment Strategies for Multiple Sclerosis: A 5-Year Population-Based Study | Neurology International | Marcello Moccia Giuseppina Affinito Giuseppina Marrazzo Tiziana Ciarambino Paolo Di Procolo | 2024/3/29 |
Unmet needs and gaps in the identification of secondary progression in multiple sclerosis: a Southern Italy healthcare professionals’ perspective | Giacomo Lus Marco André Bassano Vincenzo Brescia Morra Simona Bonavita Antonio Gallo | 2023/1 | |
Multiple sclerosis patients treated with cladribine tablets: expert opinion on practical management after year 4 | Diego Centonze Maria Pia Amato Vincenzo Brescia Morra Eleonora Cocco Nicola De Stefano | 2023/7 | |
Ocrelizumab effect on humoral and cellular immunity in multiple sclerosis and its clinical correlates: a 3-year observational study | Journal of Neurology | Nicola Capasso Raffaele Palladino Vincenza Cerbone Antonio Luca Spiezia Bianca Covelli | 2023/1 |
Hematopoietic stem cell transplantation in people with active secondary progressive multiple sclerosis | Neurology | Giacomo Boffa Alessio Signori Luca Massacesi Alice Mariottini Elvira Sbragia | 2023/3/14 |
Multimodal imaging in differential diagnosis between papilledema and choroidal neovascularization associated with morning glory syndrome | European Journal of Ophthalmology | Gilda Cennamo Daniela Montorio Vincenzo Brescia Morra Ciro Costagliola | 2023/11 |
Sexual dysfunction in people with multiple sclerosis: The role of disease severity, illness perception, and depression | Journal of clinical medicine | Cristiano Scandurra Laura Rosa Antonio Carotenuto Marcello Moccia Sebastiano Arena | 2023/3/13 |
Effectiveness of Ocrelizumab in Primary Progressive Multiple Sclerosis: a Multicenter, Retrospective, Real-world Study (OPPORTUNITY) | Neurotherapeutics | Clara G Chisari Assunta Bianco Vincenzo Brescia Morra Massimiliano Calabrese Fioravante Capone | 2023/10/1 |
Epidemiological and immune profile analysis of Italian subjects with endometriosis and multiple sclerosis | Journal of Clinical Medicine | Brunella Zizolfi Virginia Foreste Simona Bonavita Valentina Rubino Giuseppina Ruggiero | 2023/3/4 |
Effectiveness of teriflunomide on No Evidence of Disease Activity and cognition in relapsing remitting multiple sclerosis: results of the NEDA3PLUS study | Journal of Neurology | Maria Pia Amato Roberto Bergamaschi Diego Centonze Massimiliano Mirabella Girolama Alessandra Marfia | 2023/10 |
Alemtuzumab-Related Lymphocyte Subset Dynamics and Disease Activity or Autoimmune Adverse Events: Real-World Evidence | Journal of Clinical Medicine | Elisabetta Signoriello Giacomo Lus Francesco Saccà Marco Puthenparampil Cinzia Coppola | 2023/2/22 |
Google Maps Timeline: An open-access digital tool to monitor walking abilities in people with multiple sclerosis | Multiple Sclerosis Journal–Experimental, Translational and Clinical | Daniele Caliendo Anna Puca Luigi Lavorgna Antonio Carotenuto Maria Petracca | 2023/7 |
Cognitive trajectories in multiple sclerosis: a long-term follow-up study | Neurological Sciences | Antonio Carotenuto Teresa Costabile Giuseppe Pontillo Moccia Moccia Fabrizia Falco | 2022/2 |
Long-term follow-up (up to 11 years) of an Italian pediatric MS cohort treated with Natalizumab: a multicenter, observational study | Neurological Sciences | Damiano Baroncini Angelo Ghezzi Clara Guaschino Lucia Moiola Massimo Filippi | 2022/11 |
Persistence, adherence, healthcare resource utilization and costs for ocrelizumab in the real-world of the Campania Region of Italy | Journal of Neurology | Marcello Moccia Giuseppina Affinito Giulia Berera Giuseppina Marrazzo Raffaele Piscitelli | 2022/12 |